Nutra Pharma Corp. operates as a bio pharmaceutical company. The company is headquartered in Plantation, Florida and currently employs 4 full-time employees. The company went IPO on 2001-10-09. The firm's drug candidates include RPI-MN and RPI-78M. Additionally, the Company markets drug products for sale for the treatment of pain under the brand Nyloxin and Pet Pain-Away. Its pain relief categories include arthritis pain, chronic back pain, headaches and migraines, and knee and joint pain. Its over the counter (OTC) homeopathic products include Nyloxin Topical Gel, Extra Strength Nyloxin Topical Gel, Nyloxin Oral Spray, Extra Strength Nyloxin Oral Spray, Nyloxin Topical Gel Roll On, Nyloxin Professional Size Pump Topical Gel and Pet Pain Away. The firm holds approximately 21 patents in their portfolio.
Follow-Up Questions
Who is the CEO of Nutra Pharma Corp?
Dr. Michael Flax is the Chairman of the Board of Nutra Pharma Corp, joining the firm since 2001.
What is the price performance of NPHC stock?
The current price of NPHC is $0.0001, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Nutra Pharma Corp?
Nutra Pharma Corp belongs to Biotechnology industry and the sector is Health Care
